Sort By:
Featured

RSV Vaccine

The purpose of the research study is to evaluate the safety and effectiveness of the study vaccine to prevent respiratory syncytial virus (RSV). The research study will last approximately 14 months with 9 visits to our office. There is no cost for participating in the research study and you will be compensated up to $675 for your time and travel, if you qualify.

View Trial Details
Ages 60 - 80
Compensation* $675
Study Topics Vaccines

*Compensation for time and travel may be available to those who qualify.

Featured

Small Pox Vaccine

This research study will evaluate the safety and effectiveness of a vaccine to protect against Smallpox. This study will last approximately up to 39 weeks with 6 number of visits to our office and 1 telephone call. While the World Health Organization officially declared successful global eradication in 1980, the threat of a small pox outbreak still exists though bioterrorism and rish of natural re-emergence of the virus.

View Trial Details
Ages 18 - 45
Compensation* $475
Study Topics Vaccine

*Compensation for time and travel may be available to those who qualify.

Lyme Disease Vaccine (12 Months)

Prevention of Lyme disease will help reduce the lifetime complications the disease may bring if the disease is not caught early enough. The purpose of this study is to evaluate the effectiveness of an investigational Lyme disease vaccine. This study will be conducted over a 12 month period with 8 in-person visits to our office.

View Trial Details
Ages 18 - 65
Compensation* $675
Study Topics Vaccine

*Compensation for time and travel may be available to those who qualify.

Pneumococcal Vaccine

This study is to evalute the safety and effectiveness of a study vaccine that may provide broader coverage against the leading serotypes associated with pneumococcal disease. The study will last approximately 6 months with two visits to our office and two telephone calls.

View Trial Details
Ages 50+
Compensation* $110
Study Topics Vaccines

*Compensation for time and travel may be available to those who qualify.

Lyme Disease Vaccine (18 Months)

The purpose of this study is to evaluate the effectiveness of a Lyme Disease Vaccine. The study will last approximately 18 months with 8 visits to our office. Study related care throughout the study is provided to you at no cost. Compensation is available for time and travel for those who qualify.

View Trial Details
Ages 18 - 65
Compensation* $750
Study Topics Lyme Disease Vaccine

*Compensation for time and travel may be available to those who qualify.

E. Coli Vaccine

RCR is currently enrolling healthy 60-85 year olds to evaluate a vaccine that could potentially prevent E. Coli that can cause sepsis.

View Trial Details
Ages 60 - 85
Study Topics Vaccine

Pediatrics Meningitis Vaccine

Two month old patients of Legacy Pediatrics may have an opportunity to participate in this study.

View Trial Details
Ages 0 - 1
Study Topics Pediatric, Vaccine

C. Diff. Vaccine

Investigational vaccine to prevent Clostridium Difficile

View Trial Details
Ages 60+
Compensation* $250
Study Topics Vaccines

*Compensation for time and travel may be available to those who qualify.